SNTI SENTI BIOSCIENCES HOLDINGS, INC.
Research report · from SEC EDGAR · close 2026-07-30
$0.36 +3.9%
$11.2M mkt cap
executive summary
SENTI BIOSCIENCES HOLDINGS, INC. (SNTI) is a $11.2M company. Revenue is $22,000 at a -279264% net margin. It is not yet profitable. Our health score is F (17/100). 3 red flags on file. It may need to raise cash (dilution risk).
⛔Going-concern warning
Auditor flagged substantial doubt about the company continuing for the next 12 months — a raise is usually required.
⛔Bankruptcy-risk zone
Altman Z-Score is in the distress zone (-13.87).
⚠Weak fundamentals
Piotroski F-Score of 2/9 — most quality checks are failing.
who's buying
Insider buys / sells
0 / 0
Cash & ST investments
$8.9M
Operating cash flow
-$43.4M
Assembled from SEC EDGAR (XBRL, Form 4, 13F, filings), STOCK Act disclosures, and end-of-day prices — every figure is real and sourced; nothing is fabricated or predicted. Filings lag 40–90 days. Educational, not investment advice. Generated 2026-07-30 by stocktools.ai.